Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

NCT06417190 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Muscle-Invasive Bladder Carcinoma
Tumor

Interventions

DRUG: Trimodal therapy (TMT) within 45 days of neoadjuvant chemotherapy (NAC)

Sponsor

Leslie Ballas